Abstract Evidence of the safety of some anti-seizure medicines (ASMs) during pregnancy remains uncertain. We conducted a population-based cohort study of singleton pregnancies in Scotland conceived between 01/04/2010-02/07/2023. Exposure was ‘any ASM’ prescription issued 28 days prior to conception up to pregnancy end. Seven monotherapies were also examined: valproate, topiramate, carbamazepine, lamotrigine, levetiracetam, gabapentin and pregabalin.
Stuart McTaggart
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Stuart
Contact Stuart, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack